Pyrazinoic Acid Inhibits the Bifunctional Enzyme (Rv2783) in <i>Mycobacterium tuberculosis</i> by Competing with tmRNA
Pyrazinamide (PZA) is a key drug for tuberculosis treatment. The active form of PZA, pyrazinoic acid (POA), appears to inhibit multiple targets in <i>M. tuberculosis.</i> Recently, the bifunctional enzyme Rv2783 was reported as a new target of POA. However, the mechanism by which POA inh...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/8/4/230 |